Yttrium Y 90 ibritumomab tiuxetan: An anticancer drug that is a combination of the radioisotope yttrium-90 and a monoclonal antibody, a produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.
